These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 14073002)

  • 1. CITRIC ACID IN METASTASIZING CARCINOMA OF THE PROSTATE GLAND.
    LUTWAK-MANN C
    Natl Cancer Inst Monogr; 1963 Oct; 12():307-8. PubMed ID: 14073002
    [No Abstract]   [Full Text] [Related]  

  • 2. Citric acid in human prostatic secretion and metastasizing cancer of prostate gland.
    MARBERGER H; MARBERGER E; MANN T; LUTWAK-MANN C
    Br Med J; 1962 Mar; 1(5281):835-6. PubMed ID: 14469565
    [No Abstract]   [Full Text] [Related]  

  • 3. THE ROLE OF CITRIC ACID IN THE PHYSIOLOGY OF THE PROSTATE. 3. LACTATE/CITRATE RATIOS IN BENIGN AND MALIGNANT PROSTATIC HOMOGENATES AS AN INDEX OF PROSTATIC MALIGNANCY.
    COOPER JF; FARID I
    J Urol; 1964 Nov; 92():533-6. PubMed ID: 14226486
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of citric acid in the physiology of the prostate: a preliminary report.
    COOPER JF; IMFELD H
    Trans West Sect Am Urol Assoc; 1958; 25():153-61. PubMed ID: 13603579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolism of the citric acid in prostatic fluid].
    Hirakawa T
    Hinyokika Kiyo; 1965 Aug; 11(8):717-24. PubMed ID: 5890895
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.
    Liu Y
    Prostate Cancer Prostatic Dis; 2006; 9(3):230-4. PubMed ID: 16683009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of citric acid in the mammary gland. 1. The effect of p-nitrophenol on the synthesis and oxidation of citric acid by homogenates of the mammary gland.
    TERNER C
    Biochem J; 1955 May; 60(1):88-95. PubMed ID: 14363189
    [No Abstract]   [Full Text] [Related]  

  • 8. Unusual prostate carcinoma characterized by extensive metastasis, significantly increased serum level of prostatic-specific antigen,and neuroendocrine differentiation: a case report.
    Hu YX; Ye J; Jiang Y; Zhang QF; Wu YL; Chen YY
    Chin Med J (Engl); 2005 Feb; 118(3):258-61. PubMed ID: 15740661
    [No Abstract]   [Full Text] [Related]  

  • 9. Small cell carcinoma of the prostate with hypercalcemia.
    Hanazawa K; Higashi N; Kawachi Y; Suzuki F; Ishi K; Fujime M
    Int J Urol; 2005 Jan; 12(1):108-10. PubMed ID: 15661065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma of the disseminated prostate in a cat.
    Tursi M; Costa T; Valenza F; Aresu L
    J Feline Med Surg; 2008 Dec; 10(6):600-2. PubMed ID: 18621560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency].
    Song DX; Chen AM; Guo FJ; Liao H; Xie BZ; Zhu B; Chen C
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1197-201. PubMed ID: 18844116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of prostate carcinoma using phased-array coils: therapeutic effect and recurrence.
    Moritani T; Kademian JC; Ohgiya Y; Gokan T; Munechika H; Yoshida H; Ohta S
    Clin Imaging; 2005; 29(6):412-22. PubMed ID: 16274895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metastasis from prostate cancer. Report of 13 cases and critical analysis of the literature.
    Salvati M; Frati A; Russo N; Brogna C; Piccirilli M; D'Andrea G; Occhiogrosso G; Pichierri A; Caroli E
    J Exp Clin Cancer Res; 2005 Jun; 24(2):203-7. PubMed ID: 16110752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The opportunities of the treatment for patients with disseminated prostate gland cancer (the survey of literature)].
    Shaplygin LV; Furashov DV; Deviatov AS; Monakov DM; Segedin RE
    Voen Med Zh; 2006 Jun; 327(6):39-45. PubMed ID: 16898292
    [No Abstract]   [Full Text] [Related]  

  • 16. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
    Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
    APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basaloid carcinoma of the prostate gland. An unusual finding.
    Parada DD; López CA; Moreira O
    Arch Esp Urol; 2004 Jun; 57(5):573-8. PubMed ID: 15382579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate.
    Ray ME; Wojno KJ; Goldstein NS; Olson KB; Shah RB; Cooney KA
    Urology; 2006 Feb; 67(2):423.e5-423.e8. PubMed ID: 16461109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Chlamydia trachomatis infection of the prostate gland on the concentration of citric acid.
    Zdrodowska-Stefanow B; Ostaszewska-Puchalska I; Badyda J; Galewska Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):69-73. PubMed ID: 16642260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.